Journal Of Clinical Oncology (jco) Podcast
Using BCR-ABL Transcript Levels After 3 Months of Therapy on Imatinib is the Best Way to Predict Long-Term Outcome for Patients with CML Treated with Imatinib
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:08:55
- More information
Informações:
Synopsis
The study by Marin et al is another milestone in our understanding how to manage CML patients on tyrosine kinase inhibitors.
